AnnJi Pharmaceutical News
Dedicated to New Drug Development in Dermatology & Neurology
AnnJi’s Company Presentation is Now Live at BIOAsia-Taiwan 2022
AnnJi is a clinical-stage pharmaceutical company focusing on developing innovative therapeutics to improve the quality of life of patients with dermatological and neurological diseases.
Watch online (below or BIOAsia-Taiwan 2022 if you have registered for the conference), for the latest update of our clinical projects: AJ101 for dermatology and AJ201 for rare neurological diseases. We are seeking product development partners for the global market. Please contact us at email@example.com if you are interested in meeting with us.